BOT 4.11% 38.0¢ botanix pharmaceuticals ltd

Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-20

  1. 15,758 Posts.
    lightbulb Created with Sketch. 1440
    Fantastic announcement today. The rosacea has now unlocked acne phase 3. The hibernator as it were but the rosacea figures at 10% are very good. Who would have thought ? The best in class tag is nothing more than fantazing about the future. That's a bit of sizzle. The important thing is that we nailed the rosacea sausage. Personally canine dermatitis does not interest me in the slightest but with todays presso, we have unlocked a Pandoras box of possibility. The real worry that has enveloped BOT for the past year has just turned into an almighty hope irrespective of the share price. Nice to nail one for a change.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.015(4.11%)
Mkt cap ! $689.3M
Open High Low Value Volume
36.0¢ 38.5¢ 35.8¢ $2.121M 5.700M

Buyers (Bids)

No. Vol. Price($)
2 22200 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 246082 7
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.